Benjamin F. Edwards & Company’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-23
| Closed | -$2K | – | 2127 |
|
2024
Q1 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 2002 |
|
2019
Q1 | – | Sell |
-616
| Closed | -$28K | – | 1691 |
|
2018
Q4 | $28K | Buy |
616
+88
| +17% | +$4K | ﹤0.01% | 990 |
|
2018
Q3 | $30K | Buy |
528
+132
| +33% | +$7.5K | ﹤0.01% | 996 |
|
2018
Q2 | $26K | Buy |
396
+143
| +57% | +$9.39K | ﹤0.01% | 1016 |
|
2018
Q1 | $15K | Buy |
+253
| New | +$15K | ﹤0.01% | 1148 |
|
2017
Q2 | – | Sell |
-100
| Closed | -$5K | – | 1428 |
|
2017
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 1134 |
|
2016
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 1021 |
|
2016
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 896 |
|
2016
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 871 |
|
2016
Q1 | $3K | Sell |
100
-100
| -50% | -$3K | ﹤0.01% | 967 |
|
2015
Q4 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 855 |
|